Hoşgeldiniz. Lütfen giriş yapın ya da yeni bir hesap oluşturun

Approval of orphan-designated cancer drugs: FDA vs EMA

• Univadis Medical News
• cuma, 18.ekim 2019

Stark differences in the number of new cancer indications receiving orphan designation in the US vs Europe.

Does post-surgical opioid prescribing impact patient satisfaction?

• Univadis Medical News
• cuma, 18.ekim 2019

Findings from a survey of almost 1,000 patients who underwent common outpatient surgical procedures.

European Commission seeks experts for medical devices panels

• Univadis Medical News
• cuma, 18.ekim 2019

The deadline for receipt of expressions of interest is November 10th.

ESMO 2019 — Bladder cancer: immunotherapy on top of chemotherapy brings first improvement in decades

• Oncology Conference reports
• perşembe, 03.ekim 2019

Largest trial ever on urothelial cancer sees higher response rates with the addition of atezolizumab.

ESMO 2019 — Controversy — Should therapy be de-escalated in patients with HPV+ oropharyngeal cancer?

• Oncology Conference reports
• perşembe, 03.ekim 2019

Cure rates in oropharyngeal cancer have gone up, but the quality of life in survivors is often compromised by dysphagia and other side effects.

ESMO 2019 — Expert commentary: no hurry for radiotherapy in postoperative localised prostate cancer

• Oncology Conference reports
• perşembe, 03.ekim 2019

But be cautious: longer follow-up is needed to assess the freedom from distant metastases at ten years